Penwest Pharmaceuticals have initiated a Phase IIa Clinical Trial for A0001 due to commence in December. Screening of prospective patients is underway. The study will be conducted at the Children’s Hospital of Philadelphia. The Phase IIa Clinical Trial is a double-blind, randomised, placebo-controlled trial that includes high and low doses of A0001 and a placebo. […]
Categories
- A0001 (1)
- Antioxidants (3)
- Ataxia UK (1)
- B3 (1)
- Books (4)
- Cardiac issues (5)
- Cardiomyopathy (1)
- Christmas Cards (4)
- Clinical Trials (3)
- Clothes for disabled (1)
- Coq10 (1)
- Dublin Marathon (1)
- Education (3)
- Educational Guidelines (2)
- EPI-743 (1)
- Euro-Ataxia (2)
- EUROPLAN (1)
- Exercise (6)
- FARA (5)
- Friedreich's Ataxia Awareness Day (2)
- Friedreich's Ataxia Parents' Group (1)
- Friedreich's Ataxia Symposium (15)
- Frustration (2)
- Fundraising (22)
- Fundraising for FARA (1)
- Gene Therapy (1)
- GP Guidelines (1)
- HDAC Inhibitors (1)
- Idebenone (2)
- Inspirational Ideas (1)
- International Ataxia Awareness Day (4)
- Irish Wheelchair Association (1)
- Just Sam… (5)
- King of Greystones Triathlon (5)
- Maintaining good health (3)
- Mums' Lunch (2)
- Muscular Dystrophy Association (MDA) (1)
- National Ataxia Foundation (5)
- New Year (1)
- News (66)
- Nutrition (1)
- Open Garden (8)
- Parenting (1)
- Philadelphia (2)
- physiotherapy (3)
- Planning for the Future (1)
- Raising awareness (5)
- Rare Disease Day (5)
- Research (3)
- Ride Ataxia (9)
- Scientific Research Symposium (1)
- Seasonal flu Vaccination (1)
- Shop (1)
- Stem Cells (iPS cells) (1)
- Sulforaphane (1)
- Therapeutic Horse Riding (1)
- Treatments (3)
- Uncategorized (12)
- Visiting Philadelphia (2)
- Wijits (1)
- Women's Mini Marathon (3)
- Wordles (2)
- Working to find a cure (4)
- Yearly Clinical Recommendations (1)